These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 35725661)
1. Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis. Li DH; Lee E; Song C Allergy Asthma Clin Immunol; 2022 Jun; 18(1):57. PubMed ID: 35725661 [TBL] [Abstract][Full Text] [Related]
2. Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy. McSweeney MD; Mohan M; Commins SP; Lai SK Front Allergy; 2021; 2():715844. PubMed ID: 35387046 [TBL] [Abstract][Full Text] [Related]
3. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844 [TBL] [Abstract][Full Text] [Related]
5. Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy. Cha B; Kwon KS; Lee HL; Kim CW J Korean Med Sci; 2022 Aug; 37(32):e251. PubMed ID: 35971765 [TBL] [Abstract][Full Text] [Related]
6. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients. Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190 [TBL] [Abstract][Full Text] [Related]
7. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. Warren CM; Snow TT; Lee AS; Shah MM; Heider A; Blomkalns A; Betts B; Buzzanco AS; Gonzalez J; Chinthrajah RS; Do E; Chang I; Dunham D; Lee G; O'Hara R; Park H; Shamji MH; Schilling L; Sindher SB; Sisodiya D; Smith E; Tsai M; Galli SJ; Akdis C; Nadeau KC JAMA Netw Open; 2021 Sep; 4(9):e2125524. PubMed ID: 34533570 [TBL] [Abstract][Full Text] [Related]
8. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine. Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384 [TBL] [Abstract][Full Text] [Related]
9. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract. Gaspar A; Moura AL; Cruz C; Borrego LM Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507 [No Abstract] [Full Text] [Related]
11. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy. Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714 [TBL] [Abstract][Full Text] [Related]
12. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose. AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM Front Allergy; 2022; 3():825164. PubMed ID: 35386647 [TBL] [Abstract][Full Text] [Related]
13. Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy. Khokhar D; O'Shea KM; Akin C; Baldwin JL; Benjamin MR; Ravikumar R; Hosler M; McMorris MS; Sanders GM; Troost JP; Baptist AP; Oberdoerster DT; Kovalszki A J Allergy Clin Immunol Glob; 2022 Nov; 1(4):209-216. PubMed ID: 36090592 [TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to polyethylene glycol (PEG). Czarnobilska M; Bulanda M; Kurnik-Łucka M; Gil K Folia Med Cracov; 2021 Dec; 61(4):55-69. PubMed ID: 35180202 [TBL] [Abstract][Full Text] [Related]
20. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]